GREAT BASIN COLLEGE ASSOCIATE OF APPLIED SICENCE

GREAT BASIN COLLEGE

ASSOCIATE OF APPLIED SICENCE NURSING PROGRAM

NURS 143 Fall 2009

NURSING PROCESS IN DRUG THERAPY

COURSE SYLLABUS

2 CREDITS -- THEORY

GENERAL INFORMATION

A. Catalog Description: Introduction to pharmacological concepts that are

I. integrated throughout the nursing curriculum. Nursing process is emphasized as the framework for administering medications. Two credits theory (30 hours).

Offered Fall Semester only. Prerequisite: Admission to the Nursing Program.

B. Instructors Theory and Clinical:

Tami Gailey, MSN RN 753-2004 (Office)

934-7432 (Cell) tamarag@gwmail.gbcnv.edu

C. Office Hours:

To Be Announced

D . Schedule:

Theory

Classroom: Tuesdays: 12:45 pm to 2:45 pm

Dates: August 31, 2009– December 11, 2009

II. REQUIRED TEXTS:

Lilley, L.L., Rainforth-Collins, S., Harrington, S., Snyder, J.S. (2011).

Pharmacology and the nursingg process. (6 th ed.) St. Louis, MO:

Mosby.

Deglin, J. H. & Vallerand, A. H. (2007). Davis’s drug guide for nurses. (11 th ed.)

III. REQUIRED VIDEOS:

None required

IV. ATTENDANCE POLICY:

Students are expected to attend all classroom hours.

(See Student Handbook page 35)

V. METHOD OF INSTRUCTION:

Lecture, discussion, demonstration, small and large group work, assigned reading assignments, written assignments, computer assisted self-paced learning modules, will be utilized.

VI. THEORY EVALUATION:

Evaluation of student progress will be the successful completion of the course outcomes this will be evaluated with unit examinations. Fifteen (16) examinations will be given. Questions will be based on utilization of critical thinking skills and application of knowledge acquired in this course. Questions may be multiple- choice, fill in the blank, choose all correct answers, or other alternate formats as applicable

.

See the Outcome and Assessment area at the end of the syllabus for further specific information.

VII. CLINICAL EVALUATION:

Not Applicable

VIII. GRADING POLICY AND CRITERIA FOR NURS 257:

Course grade will be based on a percentage of total possible points according to the following scale:

100 - 94.00%= A 76.00 =C (needed to pass)

93.99-90.00%= A-

89.99-87.00%= B+

86.99-84.00%= B

83.99-80.00%= B-

79.99-77.00%= C+

75.99-70.00% = C-

69.99-67.00% = D+

66.99-64.00% = D

63.99-60.00% = D-

Below 60.00%= F

The course work must be completed on time and with a 76% or better to pass the course. All clinical rotation paperwork must be completed on time and with either a Pass or an average of 76% or better to pass the course. Late assignments will be worth 50% of the actual grade. If an assignment is more than one week late, a zero will be given for the assignment but submission of the assignment is still required.

10 Unit Tests = 500 points (50 points X 10 tests)

40 Med Cards = 200 points (5 points X 40 cards)

16 Online Module Quizzes = 250 points total (quizzes differ in points possible)

1 Comprehensive Final = 100 points

15 Class Activities/Participation = 150 points (10 points X 15 classes)

= 1150 total points

IX. PROCALC EXAM:

PLEASE SEE NURS 135 SYLLABUS

X. ACADEMIC HONESTY:

Great Basin College considers academic honesty one of its highest values. A student who obtains academic credit for work that is not the product of his or her own effort is being dishonest and undermining the academic integrity of the college. Students are expected to be the sole authors of their work. Use of another’s ideas must be accompanied by specific citation and reference. In addition, a learner may not submit the same work for credit in more than one course. The disciplinary consequences of plagiarism and other forms of academic dishonest include non-acceptance of work submitted, a failing grade in the course, and/or or other disciplinary action as outlined in

Great Basin College’s Student Conduct Policy.

XI. ACCOMMODATIONS FOR DISABILITIES:

GBC supports providing equal access for students with disabilities. An advisor is available to discuss appropriate accommodations with students. Please contact the ADA Officer (Julie Byrnes) in Elko at 775.753.2271 at your earliest convenience to request timely and appropriate accommodations

XII. ATTENDANCE POLICY

See page 35 of the GBC Associate Degree Nursing Handbook

GREAT BASIN COLLEGE

ASSOCIATE OF APPLIED SCIENCE IN NURSING PROGRAM

The following essential skills and critical behaviors are key constructs that are derived from GBC’s conceptual framework. They provide the theoretical underpinnings for all nursing action and roles in the associate degree nursing program.

ESSENTIAL SKILLS

ES 1-COMMUNICATION ABILITIES

The ability to effectively employ therapeutic communication techniques and appropriate interpersonal relationship skills during interactions with faculty, individuals, family members, health care team members, peers, and supervisors.

ES 2-CRITICAL THINKING

A reasoned, interactive and reflective process focused on deciding what to believe or do.





The ability to identify and challenge assumptions.

The ability to explore and imagine alternatives.

The ability to make judgments based on evidence (fact), rather than conjecture

(guesswork).

ES 3-EVIDENCE-BASED PRATICE

An informed approach to one’s practice that uses problem-solving methods that integrate best research evidence, reflection, client preference and values, and clinical expertise.

ES-4 CULTURAL COMPETENCE

The provision of nursing care that meets the individual’s valued life patterns and set of meanings.

CRITICAL BEHAVIORS

CB 1-ACCOUNTABILITY

Being answerable to self, individual, organization and/or profession for something one has done









Exercises judgment when undertaking assigned tasks

Applies knowledge when undertaking assigned tasks

Accepts responsibility for actions

Is able to answer the following questions in relation to nursing care provided:



Why was this done?

 How did I come to the decision to do this?



What makes this the most effective course of action?

CB 2-COLLABORATION

Intentional act of professionals working together toward a common goal.





Treats others with mutual respect

Identifies potential areas where conflict might arise and works toward

reducing/eliminating its occurrence.



Works cooperatively and interdependently with all members/levels

of health care team.

CB 3-SELF-LEADERSHIP

The ability to regulate, manage, direct and/or control one’s own behavior.

 Continually identifies strengths and weaknesses in relation to one’s

knowledge, performance, behavior and attitude.





Sets realistic goals for self.

Recognizes internal/external factors which contribute to and/or reduce stress

levels.

CB 4-SAFETY

A priority in the provision of nursing care for individuals and includes protecting individuals from physical and emotional injury through ongoing assessment and elimination of safety hazards.

CB 5- CARING INTERVENTIONS

Nursing behaviors and actions that assist individuals in meeting their health care

needs. Caring behaviors are nurturing, protective, compassionate, and person-

centered.

PROGRAM AND LEVEL OUTCOMES

NURSING PROCESS IN DRUG THERAPY

ADN PROGRAM

OUTCOMES

NURS 143

EXPECTED LEVEL OUTCOMES

As a Provider of Care:

T he student will demonstrate caring and critical thinking skills by assisting the individual, family or group to identify and meet basic health needs in a wide variety of settings across the continuum of care. The student will assist in the coordination of costeffective quality care using a culturally competent, collaborative and interdisciplinary approach.

As a Provider of Care:

1.

Identify the scope of pharmacology in nursing practice.

2.

3.

4.

Discuss principles of pharmacokinetics and pharmacodynamics as they apply to various medications.

Identify variations in drug activity, use, and appropriate nursing interventions for drug therapy across the life span.

Identify nursing interventions which maximize therapeutic effectiveness and minimize adverse

reactions associated specific medication regimes.

5.

Recognize factors used in the evaluation of therapeutic effectiveness and side/adverse effects of therapy.

6.

Describe the nursing process and its application in the care of patients receiving medications.

7.

Determine culturally appropriate interventions that assist the individual, family or group in the use of medications.

As a Teacher, the student will provide individual, family, or group-based education in a variety of settings to promote, maintain, and restore health from birth through death.

The student will promote a caring environment in which culturally appropriate learning activities and effective use of resources and current technology exist.

As a Manager of Care, the student will work collaboratively with all members of the health care team to achieve a costeffective, quality care that is customer focused and in keeping with the organizational goals and mission of the settings in which that care is provided.

.

As a Teacher

8.

Provide information and instruction for the individual, family, or group to achieve positive outcomes and support self-care related to the use of medications.

As a Manager of Care

9.

Work in collaboration with other members of the health care team to determine the effectiveness of a treatment regime.

As a Future Member of the Profession, the student will be accountable for the ethical, legal, and professional responsibilities related to nursing practice.

As a Future Member of the Profession

10.

Discuss ethical, legal, and professional responsibilities of the nurse in the use and administration of medications.

As an Advocate for

Others, the student will promote a climate in which individuals, families, or groups may act in their own interest, including accessing available resources, and intervenes when they are unable to act in their own interest.

As an Advocate

11.

Identify, discuss, and analyze the role of the nurse as an advocate for individuals receiving drug therapy in a variety of health care environments.

COURSE SCHEDULE

DATE READING ASSIGNMENT TEST DATE

Tuesday September 1st

Tuesday September 8 th

Tuesday September 15 th

Unit 1: Pharmacology

Basics

Lilley et al:

Chapters 1, 6, 7, 8

Self-Study Lilley Chapters:

2, 3, 4, and additional chapters mentioned in modules.

Unit 1: Pharmacology

Basics (cont)

Lilley et al:

Chapters 1, 6, 7, 8


2, 3, 4, and additional chapters mentioned in

modules.

Unit 2: Drugs Affecting the Central Nervous

System

Lilley et al.:

Chapters 11 and 14 (pages

212, 217, 220-224 only in this chapter)



Med Card 1:

Penicillin

Med Card 2:

Cephalexin

Test Unit 1: Available on

Webcampus from Thursday

September 10 th

at 4 PM thru Monday September

14 th at 11:59 PM

Med Card 3:

Morphine

Med Card 4:

Meperidine

Med Card 5:

Toradol

Med Card 6:

Percocet

**Self-Study Quizzes for

Modules 1-4 due by 11:59

PM**

Tuesday September 22 nd

Unit 2: Drugs Affecting the Central Nervous

System

Lilley et al:

Chapters 13 and 16



Tuesday September 29

Tuesday October 6 th

Unit 3: Drugs Affecting the Autonomic Nervous

System

Lilley et al:

Chapters 20 and 21



Tuesday October 13 th th

Unit 3: Drugs Affecting the Autonomic Nervous

System

Lilley et al:

Chapters 18 and 19



Unit 4: Drugs affecting the Cardiovascular and

Renal Systems

Med Card 7:

Vicodin

Med Card 8:

Imitrex

Med Card 9:

Phenergan



September 24 th at 4 PM thru Monday September

28 th

at 11:59 PM

Med Card 10:

Albuterol

Med Card 11:

Epinephrine

Med Card 12:

Dilantin

Med Card 13:

Tegretol

Med Card 14:

Metoprolol

Med Card 15:

Atropine

Med Card 16:

Ativan



October 8 th

at 4 PM thru

Monday October 12 th

at

11:59 PM

Med Card 17:

Lisinopril

Lilly et al:

Chapters 22, 23, 24





Renal Systems

Lilley et al:

Chapters 25, 26





Renal Systems

Lilley et al:

Chapters 28 and 29



Tuesday November 3 rd

Part 5: Drugs Affecting the Endocrine System

Lilley et al:

Chapters 31, 32, 34 (pages

527-529 only)


2, 3, 4, and additional

Med Card 18:

Lovastatin

Med Card 19:

Digoxin


Modules 5-8 due by 11:59

PM**

Med Card 20:

Diltiazem

Med Card 21:

Nitroglycerin

Test Unit 4 Part 1:

Available on Webcampus from Thursday October 22 th at 4 PM thru Monday

October 26 th

at 11:59 PM

Med Card 22:

Lasix

Med Card 23:

Spironolactone

Test Unit 4 Part 2:

Available on Webcampus from Thursday October 29 th at 4 PM thru Monday

November 2 nd

at 11:59

PM

Med Card 24:

Decadron

Med Card 25:

Synthroid

Med Card 26:

Insulin

Tuesday November 10 th

Part 6: Drugs Affecting the Respiratory System

Lilley et al:

Chapters 36 and 37




Unit 7: Antiinfective and

Antiinflammatory Drugs

Lilly et al:

Chapters 38, 39 and 41




Unit 7: Antiinfective and

Antiinflammatory Drugs

Lilley et al:

Chapters 40, 42 and 44



Tuesday December 1 st chapters mentioned in modules.

Unit 8: Drugs Affecting

Med Card 27:

Glucophage



November 5 th

at 4 PM thru

Monday November 9 th

at

11:59 PM

Med Card 28:

Solu-Medrol

Med Card 29:

Theophylline



November 12 th at 4 PM thru Monday November

16 th

at 11:59 PM

Med Card 30:

Levofloxacin

Med Card 31:

Ceftriaxone

Med Card 32:

Gentamicin


Modules 9-12 due**

Med Card 33:

Azithromycin

Med Card 34:

Vancomycin

Med Card 35:

Bactrim



November 26 th at 4 PM thru Monday November

30 th

at 11:59 PM

Med Card 36:

the Gastrointestinal

System

Lilley et al:

Chapters 50, 51, 52, 54



Tuesday December 8 th

Unit 9: Miscellaneous

Therapeutics: Hematologic and Dermatologic drugs

Lilley et al:

Chapters 55 and 56



FINALS WEEK Final and Hesi

Zofran

Med Card 37:

Protonix



December 3 rd

at 4 PM thru

Monday December 7 th

at

11:59 PM

Med Card 38:

Lovenox

Med Card 39:

Coumadin

Med Card 40:

Heparin



December 10 th

at 4 PM thru Monday December

14 th

at 11:59 PM


Modules 13-16 due

December 14 th at 11:59

PM**

UNIT 1:

Dates:

LEARNER OUTCOMES AND MEASUREMENT

PHARAMACOLOGY BASICS

Tuesday, September 1 st - Monday, September 14, 2009

Theory Readings & Study Guide Assignments:



Fundamentals Text (Wilkinson & Van Leuven): “Administering

Medications” pp. 472-499

 Lilley et al: Chapter 1: “Pharmacology Basics”

 Lilley et al: Chapter 5: “Medication Errors: Preventing and Responding”



Lilley et al: Chapter 6: “Patient Education and Drug Therapy”



Lilley et al: Chapter 7: “Over-the-Counter Drugs and Herbal and Dietary

Supplements”

Assessment, Measurement, & Evaluation of Learner Outcomes:



Test Unit 1: Available on Webcampus from Thursday September 10 th

at 4

PM thru Monday September 14 th at 11:59 PM



Comprehensive Final



Completion of assigned Med Cards



Ongoing Self-Study Quiz completion

Learning Outcomes:

Fundamentals text - Chapter 23 (pp 472- 499):

Course Outcomes addressed: 1, 2, 6

1.

Name at least five sources of medication information.

2.

Discuss the routes by which medications are absorbed in the body, including each one’s advantages and disadvantages.

3.

State the primary site of drug metabolism in the body. (online component)

4.

Explain how drug excretion occurs at each of the following sites: kidneys, liver, gastrointestinal tract, lungs, exocrine glands. (online component)

5.

Define onset, peak, and duration of drug action; therapeutic level, peak level, and trough level; and biological half-life. (online component)

6.

Compare and contrast primary effects, secondary effects, side effects, adverse reactions, toxic reactions, allergic reactions, anaphylactic reactions, and idiosyncratic reactions.

Chapter 1:

Course Outcomes addressed: 4, 5, 6, 10, and 11

1.

List the five phases of the nursing process.

2.

Identify the components of the assessment process for patients receiving medications, including collection and analysis of subjective and objective data.

3.

Identify goals and outcome criteria for patients receiving medications.

4.

Discuss the evaluation process as it relates to the administration of medications and as reflected by goals and outcome criteria.

5.

Briefly discuss the Five Rights of drug administration and the related professional responsibility for safe medication practice.

6.

Discuss the additional rights of drug administration that are ensured in safe medication practice.

Chapter 5:

Course Outcomes addressed: 3, 4, 5, 6, 9, 10, and 11

1.

Describe the medication errors that are most common among professional nurses and other health care professionals.

2.

Develop a framework for professional nursing practice that includes specific measures to prevent medication errors in patients of all ages.

3.

Identify the possible consequences of a medication error on a patient’s physiologic and psychologic well-being.

4.

Analyze the various ethical dilemmas associated with medication errors as related to the nursing process.

5.

Distinguish the various needs of patients in different age groups for political action related to drug therapy and the prevention of medication errors.

Chapter 6:

Course Outcomes addressed: 8

1.

Discuss the importance of patient education in the safe and efficient administration of drugs.

2.

Discuss some of the teaching and learning principles related to patient education and drug therapy across the life span that are applicable to any health care setting or to home care.

Chapter 7:

Course Outcomes addressed: 3, 4, 5, and 6

1.

Discuss the difference between prescription drugs, over-the-counter drugs, herbals, and dietary supplements.

2.

Discuss the potential dangers associated with the use of OTC drugs, herbals, and dietary supplements

UNIT 2:

Dates:

DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM

Tuesday, September 15 - Monday, September 28, 2009


 Lilley et al: Chapter 10: “Analgesic Drugs”



Lilley et al: Chapter 16; pp. 259-260, 262-266: “Central Nervous System

Stimulants and Related Drugs”

 Lilley et al: Chapter 12: “Central Nervous System Depressants and

Muscle Relaxants”

 Lilley et al: Chapter 14: “Antiparkinsonian Drugs”




Test Unit 2: Available on Webcampus from Thursday September 24th at 4

PM thru Monday September 28 th

at 11:59 PM



Comprehensive Final








Chapter 10:

Course Outcomes addressed: 2-10

1.

Define analgesia.

2.

Describe pharmacologic and non-pharmacologic approaches for the management and treatment of acute and chronic pain.

3.

Discuss the use of nonopioids, nonsteroidal antiinflammatory drugs (NSAIDs), and opioids (opioid agonists and partial opioid agonists and antagonists) in the management of acute and chronic pain.

4.

Identify the various drugs that are classified within the nonnarcotic and narcotic drug groups.

5.

Discuss the difference between opioid agonist, agonist-antagonist, and antagonist drugs and their specific use in the management of acute and chronic pain.

6.

Compare the mechanisms of action, drug effects, indications, adverse effects, cautions, contraindications, drug-drug and drug-food interactions, dosages, and routes of administration for non-narcotic and narcotic drugs (agonist and partial agonist-antagonist narcotics).

Chapter 16:

Course Outcomes addressed: 2-6, 8

1.

Identify the various central nervous system (CNS) stimulants used to treat migraine headaches and their indications, contraindications, cautions, and drug interactions.

2.

Discuss the therapeutic effects and adverse effects associated with the use of CNS stimulants used to treat migraine headaches.

3.

Briefly describe the mechanisms of action, dosage forms, routes of administration, adverse effects, toxic effects, cautions, contraindications, and drug

interactions associated with the various CNS stimulants use to treat migraine headaches.

Chapter 12:


1.

Describe the impact of CNS depressant on all body systems.

2.

Differentiate between the following terms: sedative-hypnotic drugs, barbiturates, benzodiazepines, muscle relaxants, and non-benzodiazepine drugs.

3.

Identify the specific drugs within each of the category of CNS depressants.

4.

Contrast the mechanism of action, indications, adverse effects, toxic effects, cautions, contraindications, dosage forms, routes of administration, and drug interactions of barbiturates, benzodiazepines, muscle relaxants, nonbenzodiazepines, and miscellaneous sedative-hypnotic drugs.

5.

Discuss the nursing process as it relates to the nursing care of a patient receiving any CNS depressants.

Chapter 14:


1.

Briefly discuss the pathophysiology related to Parkinson’s disease (PD).

2.

Identify the different classes of medications used as antiparkinsonian drugs, including first and second line of drugs used in therapy.

3.

Discuss the mechanisms of action, dosages, indications, routes of administration, contraindications, cautions, adverse effects, and toxic effects associated with the use of antiparkinsonian drugs.

UNIT 3:

Dates:

DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM

Tuesday, September 29 - Monday, October 12, 2009


 Lilley et al: Chapter 17: “Adrenergic Drugs”

 Lilley et al: Chapter 18: “Adrenergic-Blocking Drugs”

 Lilley et al: Chapter 19: “Cholinergic Drugs”

 Lilley et al: Chapter 20: “Cholinergic-Blocking Drugs”




Test Unit 3: Available on Webcampus from Thursday October 8 th

at 4 PM thru Monday October 12th at 11:59 PM



Comprehensive Final








Chapter 17


1.

Briefly discuss the sympathetic nervous system in relation to drug therapy— specifically, the effects of adrenergic stimulation or sympathomimetic effects.

2.

List the various drugs classified as adrenergic agonists or sympathomimetics.

3.

Discuss the mechanisms of action, therapeutic effects, indications, adverse and toxic effects, cautions, contraindications, interactions, and available antidotes to overdosage for the various adrenergic agonists.

4.

Discuss the nursing process as it relates to the administration of adrenergic drugs.

Chapter 18


1.

Discuss the normal anatomy and physiology of the autonomic nervous system as it pertains to adrenergic-blocking drugs or sympatholytics.

2.

List examples of specific drugs categorized as adrenergic antagonists or adrenergic blockers, including



- and



-blockers.

3.

Discuss the mechanisms of action, therapeutic effects, indications, adverse and toxic effects, cautions, contraindications, dosages, and routes of administration for the various



-blockers, nonselective



-blockers, and



1

- and



2

-blockers.

4.

Identify the antidotes used in the treatment of adrenergic-blocking drug overdosage.

5.

Discuss the nursing process as it relates to the administration of adrenergicblocking drugs.

Chapter 19


1.

Briefly discuss the normal anatomy and physiology of the autonomic nervous system (ANS).

2.

Cite various examples of the cholinergic drugs, including newer drug therapy for treating Alzheimer's disease and dementia-related conditions.

3.

Discuss the mechanisms of action, therapeutic effects, indications, adverse effects, dosage amounts, and routes of administration as well as any antidotes for the various .

4.

Discuss the nursing process as it relates to the administration of the various cholinergic drugs.

Chapter 20


UNIT 4:

SYSTEM

Dates:

1.

Describe the function of the cholinergic receptors with contrast of stimulation versus blocking of these receptors.

2.

List drugs that are cholinergic blockers.

3.

Discuss the mechanisms of action, therapeutic effects, indications, adverse and toxic effects, dosages, routes of administration, contraindications, cautions, and drug interactions of the various anticholinergic drugs.

4.

Discuss the nursing process as it relates to the administration of cholinergicblocking drugs.

DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL

Tuesday, October 13 - Monday, November 2, 2009




Lilley et al: Chapter 21: “Positive Inotropic Drugs”



Lilley et al: Chapter 22: “Antidysrhythmic Drugs”



Lilley et al: Chapter 23: “Antianginal Drugs”



Lilley et al: Chapter 24: “Antihypertensive Drugs”

 Lilley et al: Chapter 25: “Diuretic Drugs”



Lilley et al: Chapter 27: “Coagulation Modifier Drugs”

 Lilley et al: Chapter 28: “Antilipemic Drugs”




Test Unit 4 Part 1: Available on Webcampus from Thursday October 22 nd at 4 PM thru Monday October 26 th at 11:59 PM



Test Unit 4 Part 2: Available on Webcampus from Thursday October 29 th at 4 PM thru Monday November 2 nd

at 11:59 PM



Comprehensive Final








Chapter 21


1.

Differentiate between the following terms: inotropic, chronotropic, and dromotropic.

2.

Briefly discuss the effect of cardiac glycosides and other positive inotropic drugs on the failing and/or diseased heart.

3.

Compare the mechanisms of action, pharmacokinetics, indications, dosages, dosage forms, routes of administration, cautions, contraindications, adverse effects, and toxicity of the cardiac glycosides and other positive inotropics.

4.

Identify significant drug, laboratory test, and food interactions associated with cardiac glycosides and other positive inotropic drugs.

5.

Apply the nursing process for patients undergoing treatment with cardiac glycosides or other positive inotropics.

Chapter 22


1.

Describe the anatomy and physiology of a normal heart, including conduction, rate, and rhythm, and compare them with those of a heart with abnormal conduction and/or rhythm.

2.

Define the term dysrhythmia and explain its causes and consequences for the patient.

3.

Contrast the various classes of antidysrhythmic drugs, citing prototypes in each class and describing their mechanisms of action, indications, routes of administration, dosing, any related drug protocols, adverse effects, cautions, contraindications, drug interactions, and any toxic reactions.

4.

Apply the nursing process for patients undergoing treatment with antidysrhythmics.

Chapter 23


1.

Summarize the pathophysiology of myocardial ischemia and explain the subsequent experience of angina.

2.

Describe the various factors that may precipitate angina as well as measures that decrease its occurrence.

3.

Contrast the major classes of antianginal drugs (nitrates, calcium channel blockers, and



-blockers) with regard to their mechanisms of action, dosage forms, routes of administration, cautions, contraindications, drug interactions, adverse effects, patient tolerance, toxicity, and patient education.

4.

Apply all phases of the nursing process related to the administration of antianginal drugs.

Chapter 24


1.

Define hypertension, with comparison of primary and secondary hypertension and their related manifestations.

2.

Describe the protocol for treating hypertension as detailed in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and

Treatment of High Blood Pressure (JNC-7).

3.

List the criterion pressure values (in millimeters of mercury) for the new hypertension categories of normal pressure, prehypertension, hypertension stage

1, and hypertension stage 2 as defined in JNC-7.

4.

Using the most recent guidelines, compare the various drugs used in the pharmacologic management of hypertension with regard to mechanism of action, specific indications, adverse effects, toxic effects, cautions, contraindications, dosages, and routes of administration.

5.

Discuss the rationale for the nonpharmacologic management of hypertension.

Chapter 25


1.

Describe the normal anatomy and physiology of the renal system.

2.

Briefly discuss the impact of the renal system on blood pressure regulation.

3.

Describe how diuretics work in the renal system.

4.

Distinguish among the different classes of diuretics with regard to mechanism of action, indications, dosage, routes of administration, adverse effects, toxicity, cautions, contraindications, and drug interactions.

5.

Apply all phases of the nursing process for patients receiving diuretics.

Chapter 27


1.

Discuss the mechanisms of action of coagulation modifiers such as anticoagulants, antiplatelet drugs, antifibrinolytics, and thrombolytics.

2.

Compare the indications, cautions, contraindications, adverse effects, routes of administration, and dosages of the various coagulation modifiers.

3.

Discuss the administration procedures for the various coagulation modifiers.

4.

Identify drug interactions associated with the use of coagulation modifiers, specific observations related to their use, and any available antidotes.

5.

Apply all phases of the nursing process for patients receiving anticoagulants, antiplatelet drugs, antifibrinolytics, and thrombolytics.

Chapter 28


1.

Discuss the different types of lipoproteins and their role in cardiovascular diseases and in hyperlipidemia.

2.

List the various drug classes with specific drugs in each class that are used to treat hyperlipidemia.

3.

Compare the various drugs used to treat hyperlipidemia, including the rationale for treatment, indications, mechanisms of action, dosages, routes of administration, adverse effects, toxicity, cautions, contraindications, and associated drug interactions.

4.

Apply all phases of the nursing process for the patient receiving an antilipemic drug.

UNIT 5:

Dates:

DRUGS AFFECTING THE ENDOCRINE SYSTEM

Tuesday, November 3 - Monday, November 9, 2009


 Lilley et al: Chapter 30: “Thyroid and Antithyroid Drugs”

 Lilley et al: Chapter 31: “Antidiabetic Drugs”




Test Unit 5: Available on Webcampus from Thursday November 5 th

at 4

PM thru Monday November 9 th at 11:59 PM



Comprehensive Final








Chapter 30


1.

Discuss the various functions of the thyroid gland and related hormones.

2.

Describe the differences in the diseases resulting from the hyposecretion and hypersecretion of the thyroid gland.

3.

Identify the various drugs used to treat the hyposecretion and hypersecretion states of the thyroid gland.

4.

Discuss the mechanisms of action, indications, dosages, routes of administration, contraindications and cautions, and adverse effects related to the various drugs used to treat hypothyroidism and hyperthyroidism.

5.

Apply and discuss all phases of the nursing process for patients receiving thyroid replacement as well as for patients receiving antithyroid drug.

Chapter 31


1.

Contrast type 1 and type 2 diabetes mellitus with regard to age of onset, signs and symptoms, pharmacologic and nonpharmacologic treatment, incidence, and etiology.

2.

Discuss the various factors influencing blood glucose level in nondiabetic individuals and in patients with either type of diabetes mellitus.

3.

Identify the various drugs used to manage type 1 and type 2 diabetes mellitus.

4.

Discuss the mechanisms of action, indications, contraindications, cautions, drug interactions, and adverse effects associated with the various categories of insulin and the various oral hypoglycemic drugs.

5.

Compare rapid-, short-, intermediate-, and long-acting insulins in regard to their onset of action, peak effects, duration of action, indications, adverse effects, cautions, contraindications, drug interactions, dosages, and routes.

6.

Compare the signs and symptoms and related treatment of hypoglycemia and hyperglycemia.

7.

Discuss and apply all phases of the nursing process for patients with type 1 or type 2 diabetes with a focus on medication regimens.

UNIT 6:

Dates:

DRUGS AFFECTING THE RESPIRATORY SYSTEM

Tuesday, November 10th - Monday, November 16, 2009




Lilley et al: Chapter 35: “Antihistamines, Decongestants, Antitussives,

Expectorants”



Lilley et al: Chapter 36: “Bronchodilators and Other Respiratory Drugs”





at 4

PM thru Monday November 16 th

at 11:59 PM








Chapter 35


1.

Provide specific examples of the drugs categorized as antihistamines, decongestants, antitussives, and expectorants.

2.

Discuss the mechanisms of action, indications, contraindications, cautions, drug interactions, adverse effects, dosages, and route of administration for antihistamines, decongestants, antitussives, and expectorants.

3.

Discuss and apply all phases of the nursing process for patients taking any of the antihistamines, decongestants, antitussives, and/or expectorants.

Chapter 36


1.

Describe the anatomy and physiology of the respiratory system.

2.

Discuss the impact of respiratory drugs on various lower and upper respiratory tract diseases and conditions.

3.

List the various classifications of drugs, with specific examples of each class.

4.

Discuss the mechanisms of action, indications, contraindications, cautions, drug interactions, dosages, routes of administration, adverse effects, and toxic effects of the bronchodilators and other respiratory drugs.

5.

Discuss and apply all phases of the nursing process for patients who use bronchodilators and other respiratory drugs.

UNIT 7:

Dates:

ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS

Tuesday, November 17 - Monday, November 30, 2009


 Lilley et al: Chapter 37: “Antibiotics Part 1”

 Lilley et al: Chapter 38: “Antibiotics Part 2”

 Lilley et al: Chapter 39: “Antiviral Drugs”

 Lilley et al: Chapter 40: “Antitubercular Drugs”

 Lilley et al: Chapter 41: “Antifungal Drugs”

 Lilley et al: Chapter 44: “Antiinflammatory, Antigheumatic, and Related

Drugs”





at 4

PM thru Monday November 30 th at 11:59 PM



Comprehensive Final








Chapter 37


1.

Discuss the general principles of antibiotic therapy.

2.

Explain how antibiotics work to rid the body of infection.

3.

Discuss the pros and cons of antibiotic use with attention to the overuse or abuse of antibiotics and development of drug resistance.

4.

Classify the various antibiotics by general category, including sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines.

5.

Discuss the mechanisms of action, indications, cautions, contraindications, routes of administration, and drug interactions for the sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines.

6.

Identify drug-specific adverse effects and toxic effects of each of the antibiotic classes listed earlier and cite measures to decrease their occurrence.

7.

Discuss the concept of superinfection, including how it occurs and how to prevent it.

8.

Discuss and apply all phases of the nursing process for patients receiving drugs in each of the following classes of antibiotic: sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines.

Chapter 38


1.

Review the advantages and disadvantages associated with use of antibiotics with discussion of overuse/abuse of antibiotics, development of drug resistance, superinfections, and antibiotic-associated colitis.

2.

Discuss the indications, cautions, contraindications, mechanisms of action, adverse effects, toxic effects, routes of administration, and drug interactions associated with aminoglycosides, fluoroquinolones, clindamycin, metronidazole, nitrofurantoin, vancomycin, and miscellaneous antibiotics.

3.

Discuss and apply all phases of the nursing process for the patient receiving antibiotics.

Chapter 39


1.

Describe the various effects of viruses in the human body.

2.

Discuss the process of immunosuppression in patients with viral infections, specifically those with HIV.

3.

Discuss the stages of AIDS and various drugs used to manage/treat the illness.

4.

Discuss the mechanism of action, indications, contraindications, cautions, routes, adverse effects, and toxic effects associated with the various antiviral and antiretroviral drugs.

5.

Discuss and apply all phases of the nursing process for patients receiving antiviral and antiretroviral drugs.

Chapter 40


1.

Identify the various first-line and second-line drugs indicated for the treatment of tuberculosis.

2.

Discuss the mechanisms of action, dosages, adverse effects, routes of administration, special dosing considerations, cautions, contraindications, and drug interactions associated with the various antitubercular drugs.

3.

Discuss and apply all phases of the nursing process for patients receiving antitubercular drugs.

Chapter 41


1.

Identify the various antifungal drugs.

2.

Describe the mechanisms of action, indications, contraindications, routes of administration, adverse and toxic effects, and drug interactions associated with the use of the various antifungal drugs.

3.

Discuss and apply all phases of the nursing process for patients receiving antifungal drugs.

Chapter 44


1.

Discuss the inflammatory response and the part it plays in the generation of pain.

2.

Compare the various disease processes that are often identified as inflammatory in nature, such as rheumatoid arthritis, osteoarthritis, degenerative joint disorders, and gout.

3.

Compare the various nonsteroidal antiinflammatory drugs (NSAIDs), antigout drugs, and antiarthritic drugs in relation to their mechanisms of action, indications, adverse effects, dosage ranges, cautions, contraindications, drug interactions, and toxicities.

4.

Discuss and apply all phases of the nursing process for the patient receiving

NSAIDs, antigout drugs antiarthritic drugs, and other antiinflammatory drugs.

UNIT 8:

Dates:

DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM

Tuesday, December 1 - Monday, December7, 2009


 Lilley et al: Chapter 51: “Acid-Controlling Drugs”

 Lilley et al: Chapter 52: “Antidiarrheals and Laxatives”

 Lilley et al: Chapter 53: “Antiemetic and Antinausea Drugs”




Test Unit 8: Available on Webcampus from Thursday December 3 rd at 4

PM thru Monday December 7 th

at 11:59 PM



Comprehensive Final








Chapter 51


1.

Discuss the physiologic influence of various pathologies, such as peptic ulcer disease, gastritis, spastic colon, gastroesophageal reflux disease, and hyperacidic states, on the health of patients and their gastrointestinal tracts.

2.

Describe the mechanisms of action, indications, cautions, contraindications, drug interactions, adverse effects, dosages, and routes of administration for the following classes of acid-controlling drugs: antacids, histamine-2 (H

2

)–blocking drugs (H

2

antagonists), proton pump inhibitors, and acid suppressants.

3.

Discuss application of all phases of the nursing process related to the administration of acid-controlling drugs.

Chapter 52


1.

Identify the various factors affecting bowel elimination and/or bowel patterns.

2.

List the various groups of drugs used to treat alterations in bowel elimination, specifically diarrhea and constipation.

3.

Discuss the mechanisms of action, indications, cautions, contraindications, drug interactions, dosages, routes of administration, and adverse effects associated with the use of the various antidiarrheal and laxative drugs.

4.

Discuss application of all phases of the nursing process for patients taking antidiarrheals or laxatives.

Chapter 53


1.

Discuss the pathophysiology of nausea and vomiting, including specific precipitating factors and/or diseases.

2.

Identify the various antiemetic and antinausea drugs and their drug classification groupings.

3.

Describe the mechanisms of action, indications for use, contraindications, cautions, and drug interactions of the various categories of antiemetic and antinausea drugs.

4.

Discuss application of all phases of the nursing process for patients taking antiemetic and antinausea drugs.

Chapter 55


UNIT 9:

DRUGS

Dates:

1.

Describe the nurse’s role in the process of initiating and maintaining continuous or intermittent enteral feedings, total parenteral nutrition (TPN), and other forms of nutrition supplementation.

5.

Compare the various enteral feeding tubes, including specific uses and the special needs for patients requiring this nutrition support.

6.

Discuss the mechanisms of action, cautions, contraindications, routes of administration, interactions, adverse effects, and related complications associated with enteral and parenteral nutrition supplementation.

7.

Discuss application of all phases of the nursing process for patients receiving enteral and parenteral supplemental feedings.

THERAPEUTICS: HEMATOLOGIC AND DERMATOLOGIC

Tuesday, December 8 - Monday, December 14, 2009




Lilley et al: Chapter 56: “Blood Forming Drugs”



Lilley et al: Chapter 557: “Dermatologic drugs”




Test Unit 9: Available on Webcampus from Thursday December 10 th

at 4

PM thru Monday December 14th at 11:59 PM



Comprehensive Final








Chapter 56


1.

Discuss the various conditions requiring treatment with blood-forming drugs.

2.

Discuss the mechanisms of action, cautions, contraindications, drug interactions, uses, dosages, special administration techniques, and measures to enhance the effectiveness of and decrease adverse effects related to the various blood-forming drugs.

3.

Discuss application of all phases of the nursing process related to the administration of blood-forming drugs.

Chapter 57


1.

Describe the different disorders, infections, and conditions commonly affecting the skin.

2.

Identify the various dermatologic drugs used to treat these disorders, infections, and infestations, with description of the various classifications.

3.

Discuss the mechanisms of action, indications, contraindications, cautions, application techniques, and adverse effects associated with the various topical dermatologic drugs.

4.

Discuss application of all phases of the nursing process for patients using topical dermatologic drugs.

GREAT BASIN COLLEGE ASSOCIATE OF APPLIED SICENCE

Related documents

Products

Support

GREAT BASIN COLLEGE ASSOCIATE OF APPLIED SICENCE

Related documents

Add this document to collection(s)

Add this document to saved

Suggest us how to improve StudyLib